Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	87.43	57.42	68.18	93.73	22.92	15.8
Short-Term Investments	-	-	-	0.57	0.55	0.54
Cash & Short-Term Investments	87.43	57.42	68.18	94.3	23.47	16.35
Cash Growth	63.37%	-15.78%	-27.69%	301.79%	43.57%	-40.65%
Other Receivables	2.02	3.13	2.31	1.82	4.23	11.68
Receivables	2.02	3.13	2.31	1.82	4.23	11.68
Prepaid Expenses	1.76	1.99	3.78	2.8	1.62	2.11
Other Current Assets	2.73	1.21	0.92	0.41	0.41	0.29
Total Current Assets	93.94	63.76	75.2	99.32	29.73	30.44
Property, Plant & Equipment	1.32	1.65	2.22	2.53	1.57	11.56
Other Intangible Assets	0.87	1.09	-	24.56	31.65	44.46
Total Assets	96.13	66.5	77.41	126.42	62.95	86.45
Accounts Payable	3.5	2.35	3.49	2.29	3.17	6.15
Accrued Expenses	6.02	5.75	5.64	4.02	4.32	5.32
Current Portion of Long-Term Debt	4.93	-	13.33	-	-	15.14
Current Portion of Leases	0.68	0.65	0.56	0.62	0.64	2.59
Current Income Taxes Payable	-	-	-	1.52	-	-
Other Current Liabilities	0.33	0.74	1.36	4.1	0.44	0.68
Total Current Liabilities	15.47	9.49	24.38	12.54	8.57	29.88
Long-Term Debt	-	4.39	-	14.38	16.14	5.37
Long-Term Leases	0.55	0.91	1.48	1.75	1.16	9.32
Other Long-Term Liabilities	1.46	1.18	0.16	9.74	52.05	1.62
Total Liabilities	17.48	15.96	26.01	38.42	77.92	46.19
Common Stock	3.03	2.78	2.48	1.76	1.02	0.29
Additional Paid-In Capital	534.73	486.11	476.52	247.46	161.79	121.68
Retained Earnings	-440.84	-419.63	-404.58	-296.97	-309.69	-146.07
Treasury Stock	-	-1.23	-1.34	-	-	-
Comprehensive Income & Other	-18.28	-17.49	-21.69	135.76	131.92	64.34
Shareholders' Equity	78.65	50.54	51.4	88	-14.97	40.26
Total Liabilities & Equity	96.13	66.5	77.41	126.42	62.95	86.45
Total Debt	6.16	5.95	15.37	16.76	17.94	32.42
Net Cash (Debt)	81.27	51.47	52.81	77.54	5.53	-16.07
Net Cash Growth	94.97%	-2.54%	-31.89%	1301.34%	-	-
Net Cash Per Share	0.58	0.39	0.44	0.70	0.08	-0.90
Filing Date Shares Outstanding	153.61	140.01	124.74	116.73	108	42.48
Total Common Shares Outstanding	153.52	140	124.74	116.73	67.54	19.34
Working Capital	78.47	54.27	50.82	86.78	21.16	0.56
Book Value Per Share	0.51	0.36	0.41	0.75	-0.22	2.08
Tangible Book Value	77.78	49.45	51.4	63.44	-46.62	-4.2
Tangible Book Value Per Share	0.51	0.35	0.41	0.54	-0.69	-0.22
Machinery	0.5	0.5	0.61	0.35	0.2	0.19
Leasehold Improvements	0.72	0.71	0.68	0.56	0.16	0.16

Source: S&P Capital IQ. Standard template. Financial Sources.